A new study from Auburn University provides new insights into neuronal connections, offering hope for the treatment of ...
For individuals with dominantly inherited Alzheimer disease, long-term treatment with gantenerumab may delay clinical decline ...
Panelists discuss how health care institutions are leveraging strategic referral networks and telemedicine technologies to bridge geographical barriers, connect rural patients with specialized ...
The EU medicines regulator on Friday rejected Eli Lilly's Alzheimer's drug, saying the treatment's ability to slow cognitive ...
A European regulatory committee has rejected Eli Lilly’s U.S.-approved Alzheimer’s disease treatment over potentially ...
Zunveyl (benzgalantamine) is now available for the treatment of mild to moderate dementia of the Alzheimer type in adults.
Panelists discuss how overcoming barriers to effective Alzheimer disease cognitive screening requires addressing multiple challenges including time constraints in clinical settings, inadequate ...
Send a loud and clear message to your lawmakers NOW and join AARP's fight to protect your Social Security! Help Register ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback